Maui Mokka (Coffea arabica)

Maui Mokka (Coffea arabica) is a Hawaiian coffee cultivar with no documented health benefits beyond standard coffee effects. This specialty coffee variety contains caffeine and chlorogenic acids typical of arabica coffee but lacks specific clinical research.

Origin & History

Maui Mokka is a cultivar variant of Coffea arabica developed in Ka'anapali, Maui, Hawaii, as part of University of Hawaii field trials on former Pioneer Sugar Mill land. It emerged as one of four viable varieties alongside Red Catuai, Yellow Caturra, and Typica, and is a tall-growing, low-yielding type producing small, round beans grown at low elevations around 500 feet.

Historical & Cultural Context

Maui Mokka has no documented historical use in traditional medicine systems, as it is a modern cultivar from 20th-century Hawaii field trials rather than an ancient landrace. While Coffea arabica originated in Ethiopia with traditional stimulant use, this variant lacks such historical context.

Health Benefits

• No specific health benefits documented - no clinical trials exist for this cultivar
• General coffee benefits may apply but are not studied for this variant - evidence quality: none
• Unique flavor profile suggests chemical differences but no biomedical effects documented - evidence quality: none
• As a Coffea arabica variant, may share general coffee properties but this is unverified - evidence quality: none
• No traditional medicinal use documented as this is a modern cultivar - evidence quality: none

How It Works

Maui Mokka contains caffeine which blocks adenosine A1 and A2A receptors in the brain, promoting wakefulness and alertness. The chlorogenic acids present may inhibit glucose-6-phosphatase and affect glucose metabolism, though this is not specifically studied for this cultivar. These compounds follow standard coffee metabolic pathways through cytochrome P450 enzymes in the liver.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Maui Mokka were identified in the search results. While general Coffea arabica studies exist on caffeine-related effects, none reference this Maui-specific variant, its unique profile, or biomedical outcomes.

Clinical Summary

No clinical trials exist specifically for Maui Mokka coffee cultivar health effects. General arabica coffee research shows cardiovascular and metabolic benefits, but these findings cannot be directly applied to this Hawaiian variety. The unique flavor profile suggests different phytochemical composition, but biomedical effects remain unstudied. Evidence quality for specific health claims is absent.

Nutritional Profile

Maui Mokka is a dwarf Coffea arabica cultivar grown in Hawaii, characterized by exceptionally small, round 'mokka' beans. As no cultivar-specific nutritional analysis has been published, composition is extrapolated from Coffea arabica baseline data with noted distinctions. Brewed coffee (240ml): calories 2-5 kcal, protein <0.3g, carbohydrates <1g, fat <0.1g, fiber 0g. Caffeine content is estimated lower than standard arabica at approximately 0.8-1.0% dry weight of green bean (vs. typical arabica 1.2-1.5%), reflecting a characteristic of mokka-type beans generally; a standard brewed cup may yield 60-90mg caffeine, though no Maui Mokka-specific assay is confirmed. Chlorogenic acids (primary bioactive): arabica typically contains 6-9% dry weight in green beans, predominantly 5-caffeoylquinic acid; roasting reduces this to approximately 0.5-4.5% depending on roast level. Trigonelline: approximately 0.6-1.2% dry weight green bean, partially converts to niacin (vitamin B3) during roasting, yielding roughly 0.5-1.0mg niacin per cup. Cafestol and kahweol (diterpene lipids): present at approximately 10-15mg per unfiltered cup; largely removed by paper filtration. Potassium: approximately 116mg per 240ml brewed cup. Magnesium: approximately 7mg per cup. Manganese: approximately 0.05mg per cup. Riboflavin (B2): approximately 0.01mg per cup. The distinctive chocolate and fruit aromatic profile of Maui Mokka suggests elevated concentrations of specific volatile compounds including 2-furfurylthiol and certain pyrazines, but quantitative data for this cultivar specifically is absent from published literature. Bioavailability of chlorogenic acids from coffee is moderate at 15-30% absorption.

Preparation & Dosage

No clinically studied dosage ranges for Maui Mokka in extract, powder, or standardized forms were found, as no human trials exist for this cultivar. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented, general coffee companions like L-theanine, green tea, guarana may theoretically apply

Safety & Interactions

Maui Mokka likely shares safety profile with regular coffee, including potential anxiety, insomnia, and digestive upset from caffeine content. May interact with medications metabolized by CYP1A2 enzymes including warfarin and certain antidepressants. Pregnant women should limit intake due to caffeine content. Individuals with anxiety disorders or cardiovascular conditions should exercise caution with any caffeinated coffee variety.